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 Electronic nicotine delivery systems (ENDS), or electronic cigarettes (e-
cigarettes), are battery-powered handheld devices designed to aerosolize a solution of 
nicotine and other chemicals for inhalation. The specific mechanical and chemical 
features of different ENDS affect the systemic exposure and bioavailability of the 
different chemicals in e-juices. E-cigarettes can come with different cartridge sizes, 
power outputs, e-liquid constituents, and nicotine delivery. User puff topography also 
contributes to varying toxicant exposure.  
ENDS have demonstrated potential as a cessation tool or alternative cigarette 
product due to its safety profile relative to the combustible cigarette. E-cigarettes have 
significantly lower concentrations of biomarkers of tobacco-related toxicant exposure and 
produce less and less harmful second-hand smoke compared to CC. However, ENDS 
users have significantly greater concentrations of those same biomarkers, highlighting 
that e-cigarettes do pose a harm to users’ health, even if that may be lower than CC. The 
same is observed in e-cigarette second-hand smoke as nicotine and aerosol particles were 
detected in statistically significant amounts. Its toxicity is only amplified by the 
misconception that they are safer than CC and thus pose no absolute risk, misleading 
users to use without caution.  Therefore, although ENDS do have the potential in 
reducing smoking in adults who are already addicted to nicotine, it comes with the risk of 
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dual use of conventional and electronic cigarettes and of attracting non-smokers, 
especially as seen in the youth.  
The rise in adolescent e-cigarette use can be attributed to its appeal, of both its 
flavored e-liquids and its image amongst youth that is perpetuated through the intentional 
marketing of e-cigarette manufacturers. The latent consequences of e-cigarettes are 
compounded in adolescents, who are in critical stages of brain development, habit 
formation, and social development. 
Youth report having experienced short-term clinical symptoms such as cough, 
lightheadedness, headache, and shortness of breath. Physiologically, vaping has been 
found to affect the pulmonary and cardiovascular systems. Vaping alters the equilibrium 
of the mucociliary clearance system in the pulmonary system and increases the risk of 
chronic bronchitis, cough, and phlegm. There is increased in pro-inflammatory cytokine 
secretions, increased alveolar macrophage apoptosis, impairment of phagocytosis, 
decreased ciliary beating, inhibition of the CFTR channel, and increased mucin 
expression. In the cardiovascular system, e-cigarette aerosol extract alters angiogenesis, 
oxidative stress, endothelial dysfunction, sympathetic nerve system activation, platelet 
activation and anticoagulation inhibition, and cardiac remodeling. E-cigarettes and e-
cigarette smoke have also been associated with carcinogenesis in lung epithelium and 
possibly urothelium.  
Although e-cigarettes have, on average, less nicotine compared to CC, the 
significant risk for adolescents to graduate to combustible cigarettes renders this moot. 
The factors influencing this graduation is modeled through the catalyst model, which 
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details the transition from ‘no use’ to ‘e-cigarette use’ and the transition from ‘e-cigarette 
use’ to ‘tobacco use.’ Schneider and Diehl hypothesized that the first transition is 
facilitated through a variety of factors, including flavor, health, price, role models, 
concealment, and acceptance. The subsequent transition can be attributed to the addiction 
hypothesis, accessibility hypothesis, and the experience hypothesis. It is clear from the 
numerous studies conducted, which show students who used e-cigarettes were 4-7 times 
more likely to report CC use, that e-cigarettes play a catalytic role in enabling the 
transition to conventional cigarettes. And with increased nicotine exposure, adolescents 
are subject to impairments in working and verbal memory during abstinence, changes in 
drug sensitivity and reward-related manifestations in adulthood, more severe dependence 
during adolescence, and deficits in attentional performance, impaired serial pattern 
learning, impaired context conditioning and increased anxiety and depressive-like 
behaviors in adults. They also have reduced control of motivation, reward, and pleasure. 
This culminates to the gateway hypothesis which states that nicotine can serve as a 
gateway drug that lowers the youths’ threshold for addiction to opioids, alcohol, and 
other agents.  
Recently, there has been a dramatic increase in cases of EVALI or e-cigarette or 
vaping associated lung injury, particularly in the adolescent population that is more likely 
to use illicit e-cigarettes than their adult counterparts. EVALI presents with a wide range 
of respiratory, gastrointestinal, and constitutional symptoms and is characterized as a 
sterile exogenous pneumonitis-like reaction with variable degrees of diffuse alveolar 
damage. Vitamin E acetate, common in illicit products, is strongly linked to this outbreak 
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due to its presence in a vast majority of bronchoalveolar lavage fluid samples of 
confirmed EVALI cases.  
As ENDS use has increased amongst adolescents, so have its latent consequences. 
A coordinated effort from policy makers, public health agencies, healthcare providers, 
researchers, and especially parents and educators is essential for successful protection of 
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INTRODUCTION OF ELECTRONIC CIGARETTES 
 
Composition & Use 
 
Electronic nicotine delivery systems (ENDS), also called vapes, mods, or 
electronic cigarettes (e-cigarettes) are battery-powered handheld devices designed to 
aerosolize a solution of nicotine and other chemicals for inhalation. E-cigarettes come in 
varying shapes and sizes, but most are structurally consistent with four main components, 
including: 
1. Cartridge or reservoir that holds the e-liquid, an aqueous solution of 
flavorings, nicotine or another drug, and additives [18]; 
2. Heating element or atomizer;  
3. Battery as a power source and  
4. Mouthpiece from where the aerosolized e-liquid is inhaled [44].  
The particular constituents of the e-liquid also vary depending on manufacturer. E-
liquids are generally a solution of concentrated flavorings, variable concentrations of 
nicotine, or tetrahydrocannabinol (THC) and cannabinoid (CBD) oils, and additives [18]. 
Common additives, that serve as solvents, include vegetable glycerol (VG), propylene 




Table 1: Overview about constituents in electronic cigarettes with descriptive 
statistics and best fit distributions [18] 
When using ENDS, the battery powered atomizer heats and aerosolizes the 
solution, also known as the e-liquid or e-juice, into an aerosol that the consumer can 
inhale through the mouthpiece. The ENDS are activated via a power button or through 
the act of inhaling which triggers an airflow sensor. The use of such products is often 
referred to as vaping, dabbing, or JUULing (a reference to JUUL, a specific brand of e-
cigarette).  
 
Figure 1: Different types of e-cigarette products in the market, ranging from 







Variability in ENDS  
 
Although the general structure of ENDS are comparable, individual models vary 
in their specific mechanical and chemical features.  
The cartridge sizes and refill capability differ between brands and e-cigarette 
models. Some ENDS, known as first-generation e-cigarettes or cigalikes, are shaped 
similar to conventional cigarettes and adopt a closed system model where its cartridges 
are not refillable. Others, like mods and tanks, have an open system with larger cartridges 
that hold more e-liquid and can be refilled. These differences translate to the ease of use 
of the e-cigarette, as consumers need not continually repurchase the product or refill their 
cartridge as frequently, and influences the frequency of use by the consumer.  
The different power outputs of available e-cigarettes, determined by atomizer 
resistance and battery voltage (P=V2/R), govern the heating of the atomizer and the 
amount of solution aerosolized. Therefore, the nicotine yield, or the amount of nicotine 
that emerges from the mouthpiece of the e-cigarette, and the nicotine inhaled per standard 
breath increases with greater power output, when the degree of activation is normalized, 
and nicotine delivery is more efficient. Open system ENDS, compared to closed systems, 
are less restricted in size and therefore have larger batteries that can provide power longer 
and with less resistance. Resistance in commonly marketed e-cigarettes ranges from 1.0 
to 6.5 Ω, with some ENDS having a resistance less than 1 [6]. The resistance of the 
atomizer is intrinsic to the metal it is made of, usually nichrome wire, which is 80% 
nickel and 20% chrome, but can also be made from kanthal, an alloy made from iron, 
chromium, and aluminum. Battery voltage ranges from 3 to 6 V and has been trending 
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upward with every new generation of the e-cigarette [6]. In some models of e-cigarettes, 
this feature can be adjusted by the user, personalizing the nicotine yield to their needs.  
The specific constituents and their concentrations in solution vary because the 
exact composition of e-liquids is not uniform across and within manufacturers. E-liquids 
can include the intended flavorings, nicotine or a drug, solvents, and other toxicants such 
as carcinogens, heavy metals like nickel, tin, and led, and volatile organic compounds 
(VOC) ‘’. Propylene glycol (PG) and glycerol (VG), and their ratio in different e-liquids, 
alter the delivery of nicotine and its other constituents due to their different boiling points 
and particle size. VG’s boiling point is at 290ºC while PG vaporizes at 188ºC [6]. The 
higher boiling point of VG allows the solution to reach higher temperatures and may 
influence toxicant emissions. PG yields smaller particles than VG and can penetrate and 
deposit nicotine and toxicants deeper into the alveoli of the lungs [5]. The different 
flavorings also affect the toxicity of the e-liquids, with greater concentrations of vanillin 
and cinnamaldehyde positively correlated to the overall toxicity [24].  
Thermal breakdown of the liquid ingredients also affects the specific toxicants 
that users are exposed to in the inhaled aerosol. Studies have found variable 
concentrations of formaldehyde, acetaldehyde, acetone, VOCs, polycyclic aromatic 
hydrocarbons (PAH), and reactive oxygen species (ROS) in e-cigarette aerosols, 
depending on battery voltage and solvent [6]. Kosmider et al determined that PG-based e-
liquids generated significantly higher yield of carbonyls (formaldehyde, acetaldehyde, 
and acetone) than VG-based liquids and increased battery voltage resulted in higher 
concentrations of these carbonyls. When increasing the voltage from 3.2 to 4.8V, 
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carbonyl yield increased by 4-200, which is in the reported range of 1.6-52 μg/cigarette 
[28]. Flavorings were found to have no influence on the products of thermal 
decomposition [28]. While these compounds are present at lower than or similar ranges 
as those observed in combustible cigarette (CC) vapor and present a less than or equal 
toxicity potential, some compounds, like glyoxal and methyl glyoxal, are found in e-
cigarette aerosols but not cigarette smoke [6].  
 
Table 2: Levels of carbonyl compounds in vapors generated from EC refilled with 
commercially available (A1–A10) and control (C1–C3) nicotine solutions (ng/15 
puffs; mean ± SD; N = 3) [28] 
Even the chemical structure of the nicotine delivered differs amongst brands. 
With two basic nitrogen groups, nicotine delivery can be in the form of free base nicotine 
or nicotine lactate salts, determining its rate of delivery. The free base form of nicotine is 
volatile and more likely to off gas from the aerosolized droplets early on, depositing in 
the oral cavity and upper respiratory tract. Absorption of nicotine here is slower than at 
the respiratory zone of the lungs. Nicotine salts, on the other hand, are less volatile and 
remain associated with the droplets until they reach the alveoli. At the alveoli, nicotine 
salts dissociate, and the non-polar, lipid-soluble free base can absorb quickly into the 
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pulmonary epithelium. The pharmacokinetics of nicotine salts more closely resemble that 
of conventional cigarettes, resulting in comparable rates of nicotine delivery [36].  
All these factors and more contribute to the variable systemic exposure and 
bioavailability of the different chemicals in the e-juices. This is not accounting for user 
puff topography, that describes the individual patterns and behaviors of the user including 
the length of inhalation, puff volume, successive puffs, the frequency of use, and user 
experience, which would greatly influence the safety profile of ENDS. With each 
successive puff, the temperature reached by the atomizer increases and the e-liquid is 
heated at higher temperatures, which has been shown to be directly correlated with 
nicotine delivery and thermal decomposition [42]. User's experience also affects the 
blood nicotine levels achieved.  More experienced users can achieve comparable or 
greater levels to that of CC's as they are able to puff longer and larger volumes [36]. 
Another example of how individual consumer use affects systemic exposure is the direct 
dripping method of use, where users drip the e-liquid directly onto the exposed heating 
coil system, which can reach higher temperatures than e-cigarettes that use an automatic 
wick system. This method reportedly provides a better "throat hit" and greater vapor 
production for the user. However, by using this method and aerosolizing the e-juice at 
higher temperatures, there was lower nicotine yield and greater emission of volatile 





History & Proliferation 
 
The appearance of the modern e-cigarette can be approximated to 1965 when the 
first patent was submitted by Herbert Gilbert in the US [34]. The current e-cigarette, with 
its characteristic atomizer, however, was developed in 2003 by Hon Lik, a Chinese 
pharmacist [34]. Since its spread into the U.S. market in the mid-2000s, the popularity of 
ENDS has exploded with 466 e-cigarette brands being sold by January 2014 and a net 
increase of 10.5 brands per month seen during the review period [51]. The market value 
of e-cigarettes, as of 2019, was estimated to be approximately $2.5 billion [16]. 
 
Figure 2: History of Electronic Cigarettes, juxtaposed with the proliferation of 






POTENTIAL BENEFITS OF THE E-CIGARETTE 
 
Since its inception, ENDS have been touted as a safer alternative to smoking 
combustible cigarettes, demonstrating its potential as a cessation tool or alternative 
cigarette product. A study funded by Ruyan, the company which released Lik’s electronic 
atomizing cigarette, reported that the “Ruyan® e-cigarette is designed to be a safe 
alternative to smoking. It is very safe relative to cigarettes, and also safe in absolute terms 
on all measurements we have applied” [30]. The question that now presents itself is, are 
ENDS really safer than conventional cigarettes and safe in absolute terms, without the 
bias of funding by e-cigarette companies?  
 
Toxicity of the e-cigarette  
 
Toxicant Exposure in Users 
 Combustion of tobacco, the method of nicotine delivery of traditional cigarettes, 
releases harmful and potentially harmful constituents (HPHC) including carbon 
monoxide (CO), hydrogen cyanide, ammonia, and more than 6,000 other chemicals [20]. 
These chemicals in tobacco smoke are linked to cardiovascular disease, lung disease, 
cancer, and much more. But how do e-cigarettes, which removes combustion from the 
equation, fair in terms of HPHCs that are released and taken in by users?  
 Goniewicz et al assessed groups of biomarkers of tobacco-related toxicant 
exposure, including the level of urinary nicotine metabolites, tobacco-specific 
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nitrosamines (TSNA), metals, PAHs, and VOCs in a study of 5105 participants, 
categorized into current exclusive e-cigarette users, current exclusive cigarette smokers, 
dual users, and never tobacco users [17]. They found that compared with cigarette-only 
smokers, e-cigarette-only users had significantly lower concentrations of all urinary 
nicotine metabolites, all TSNAs, cadmium, all PAHs, and 17 VOCs of those that were 
measured. Nicotine metabolite mean concentrations were approximately 93% lower, 
cadmium concentrations were 30% lower, naphthalene was 62% lower, pyrene was 47% 
lower, acrolein was 60% lower, acrylonitrile was 97% lower, and acrylamide was 59% 
lower in e-cigarette-only users [17]. The lower concentration of biomarkers translates to 
lower biological responses to diseases associated with smoking, such as cardiovascular 
diseases [41].  
 However, these values depend on the individual users’ puff topography and the 
specific ENDS that is used. For example, those who use nicotine salt-containing e-juices 
have a greater systemic exposure to nicotine due to the more efficient absorption 
mechanisms of nicotine salts versus free base nicotine. A review found that nicotine 
levels in e-juices vary considerably, with a range of 0–87.2 mg/ml [35], and with 
consumers, reporting they use 1-4 ml of nicotine salt e-juice and upwards of 10-30ml of 
free base nicotine e-liquid per day. There is an average of 22 to 36 mg of nicotine per 
pack of cigarettes. Although nicotine concentrations do not solely determine nicotine 
yield, it is positively correlated to it. And the great variability in ENDS reveals that, 




 Its independent toxicity should also not be ignored when assessing toxicity 
exposure in users. In the Goniewicz et al study, nicotine-related toxicant biomarkers of e-
cigarette users were also compared to never users. The never users had significantly 
lower mean concentrations of all major nicotine metabolites and total nicotine 
equivalents, all TSNAs, 4 metals such as lead and cadmium, 1 PAH (pyrene), and 4 
VOCs including acrylonitrile [17]. This study, and many more, have shown that using e-
cigarettes does pose a harm to users’ health, even if that may be lower than combustible 
cigarettes.  
 
Second-hand e-cigarette Aerosol 
 The use of e-cigarettes is commonly known as “vaping,” but the inhaled product 
is more accurately an aerosol composed of atomized liquid droplets. These droplets are 
then exhaled and is the only source of second-hand smoke. Combustible cigarette smoke, 
on the other hand, is made up of solid and semi-solid particles that deposit on surfaces 
and progressively become more toxic with time. Second-hand exposure to CC smoke is 
due to the exhaled smoke by the user, known as mainstream smoke, and largely the 
smoke emitted from the burning cigarette, or sidestream smoke [35]. The differences in 
the sources and composition of the second-hand smoke from combustible and electronic 
cigarettes helps explain the differing safety profiles. Compared to e-cigarettes, second-
hand CC smoke is given off in larger volumes and remains in the environment longer, 
exposing bystanders to progressively more toxic chemicals.  
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 A study by Czogala et al found that the air concentration of nicotine released by 
e-cigarettes was ten times less potent than those associated with traditional cigarettes 
[12]. The study involved 5 male participants who were dual users of e-cigarettes and 
conventional tobacco cigarettes with a nicotine dependence of 5.8 ±2.1, determined by 
the Fagerström Test for Nicotine Dependence. During the experiment, each participant 
first used their e-cigarette twice for 5 minutes each time and with a 30-minute interval, 
after which the room was decontaminated and ventilated for 5 minutes, and then smoked 
two cigarettes with a 30-minute interval between each cigarette. One-hour average air 
concentrations of nicotine, aerosol particles, carbon monoxide, and VOCs were recorded 
in the exposure chamber and calculated for each experimental condition and a baseline. 
The average nicotine concentration was 10 times higher and average aerosol particle 
concentration was 7 times higher after smoking CC than after -cigarettes[12]. No changes 
were observed in CO and toluene concentrations with ENDS use while cigarette smoking 
resulted in an average increase of 2 to 3 ppm of CO and a 3.5-fold increase of toluene 
[12]. Other VOCs detected after tobacco cigarette use were ethylbenzene, m,p-xylene, 
and 0-xylene [12]. These observations suggest that second-hand aerosol exposure from e-
cigarettes may be less harmful than second-hand exposure from traditional cigarettes. 
 Czogala et al’s study also revealed that there were significant increases in air 
nicotine and aerosol particle concentrations after e-cigarette use [12]. Nicotine levels 
were observed at 3.32±2.49 µg/m3, while at baseline nicotine was below the level of 
detection. Aerosol particle levels were detected at 151.7±86.8 µg/m3 versus 32.4±30.0 
µg/m3 at baseline. The statistically significant increases in these compounds demonstrates 
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the present potential risk of second-hand smoke from ENDS. The pleasant smell from 
flavorings, which starkly contrasts the burning of a cigarette, may mislead the public to 
believe ENDS pose no second-hand smoke risk but this is shown to be false. Currently, e-
cigarettes are legally allowed to be used in indoor public places such as vaping 
conventions and e-cigarette shops [35]. At these conventions, cloud competitions are held 
where the density and thickness of the exhaled smoke is ranked and rewarded but by 
doing so, exposing convention goers to the toxicity of secondhand smoke at levels even 
greater than observed in Czogala’s study, which measured the air toxicant concentrations 
from one user rather than hundreds. ENDS also pose a threat to indoor air quality because 
the discreetness and pleasant smell of the aerosol enables consumers to use them in areas 




Table 3: Changes in nicotine, aerosol particles (PM2.5), and carbon monoxide air 
concentration inside exposure chamber after use of e-cigarette [12] 
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Role in Smoking Cessation 
 
As was marketed in the first ENDS products, e-cigarettes continue to be sold and 
used as a tool for smoking cessation. It is seen by the public as a safer product that can be 
used to taper the nicotine concentration users are addicted to until they are no longer 
dependent on nicotine, from either combustible or electronic cigarettes. The popularity of 
this use for e-cigarettes has grown substantially. In theory, ENDS are a promising tool for 
cessation because of its lower toxicity, on average lower concentrations of nicotine, and 
the behavioral and sensory aspects of smoking addiction, like the hand to mouth motion, 
that they satisfy. Possibly used in conjunction with FDA-approved NRTs, true cessation 
rates can be achieved. 
However, there is lack of concrete evidence supporting the real-world application 
of ENDS for smoking cessation and it is not currently approved by the FDA as a smoking 
cessation aid. Of the then current randomized controlled trials and observational studies 
assessing ENDS role in cessation, Dib et al concluded in their meta-analysis that no 
credible inferences can be made due to the studies’ low certainty [13]. More recent 
studies do reveal that 1-year combustible cigarette abstinence rates are greater with e-
cigarette use compared to NRT utilization, 18.0% versus 9.9% respectively [19]. Use of 
nicotine salts could potentially increase abstinence rates because the rate of nicotine 
delivery is similar to that of traditional cigarettes, providing the same satisfaction and 
quenching their cravings better. However, 80% of participants using ENDS as a cessation 
tool were found to be using the product at the 1-year follow up [19]. This suggests that e-
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cigarette use may help smokers quit smoking traditional cigarettes, but they transfer their 
nicotine addiction to e-cigarettes. The lower concentrations of nicotine in e-cigarettes 
also pose the risk of compensatory behavior as users puff more deeply, more frequently, 
and for longer to satisfy their nicotine cravings and reduces their desire to smoke [3]. 
Rather than as smoking cessation tool, ENDS may have a role as a harm-reduced nicotine 
product. It also poses the possibility of dual use, where consumers smoke combustible 
cigarettes and use e-cigarettes. There is evidence to suggest that many e-cigarette users 
continue to smoke cigarettes [8]; exposure to dual use of combustible tobacco products 
and e-cigarette aerosols may be more deleterious to the respiratory system than either 
product alone [30]. Dual use of cigarettes and ENDS result in the greatest degree of 
toxicant exposure [17]. Thus, ENDS do have the potential in reducing smoking in adults 
who are already addicted to nicotine, though it comes with risks itself, but they have also 
been shown in recent trends to attract non-smokers, especially as seen in the youth. 
 
Comparative vs. Absolute Risk 
 
Although e-cigarettes have been shown to be equivalent to or safer than 
traditional combustible cigarettes in terms of overall toxicity, the safety profile of ENDS 
cannot be reviewed without consideration of its independent addictive potential and 
toxicity. There is an absolute risk of e-cigarette use. The primary function of an ENDS is 
to deliver nicotine and other drugs, and with that comes their addictive nature. With its 
accessibility and perception as safer than CCs and thus deemed safe overall, the effects of 
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nicotine and other toxicants are compounded, making users and bystanders, especially 
adolescents, susceptible to the known and largely unknown effects of the multitude of 
toxicants present in the E-liquid. Given e-cigarettes relatively recent introduction to the 
marketplace, further research is needed to evaluate the risks associated with e-cigarette 
use, especially contemporary patterns that include dual use of e-cigarettes and CC. The 
greatest absolute risk with e-cigarettes currently is the narrow focus on the comparative 




ADOLESCENT EXPOSURE TO E-CIGARETTES 
 
Rise of e-cigarette Use  
 
Current e-cigarette use, which is defined as use at least one day in the past 30 
days, in middle school and high school students has gained significant traction and 
continues to rise. According to the National Youth Tobacco Survey in 2011, use among 
U.S. high school students was estimated to be at 1.5% [34]. Rates, which increased to 
11.7% of high school students who then currently vaped in 2017, has grown dramatically 
to 27.5% among high school students and 10.5% among middle school students in 2019 
[10]. In just eight years, the percent of current adolescent ENDS use has increased more 
than 1,800%. This translates to over 5 million current middle and high school student 
ENDS users in 2019 and almost 1 million adolescent every day e-cigarette users [46]. 
Not only are the number of adolescent users increasing, but the frequency at which they 
are vaping is also rising substantially because of its addictive qualities. 
 
Figure 3: Trends of cigarette and e-cigarette use by middle school and high school 




From its design and features to its image amongst youth, the appeal of e-cigarettes 
to the adolescent can be seen as a major culprit for the rise of ENDS use in this 
population. First and foremost, e-cigarettes are easy to obtain and to keep for adolescents. 
They are easily accessible to the youth, with their affordable price and the abundance of 
online retailers, and, once bought, can be kept in secret from school staff and parents 
because of the unsuspecting scents and compact form. But the main appeal to adolescents 
that the e-cigarette has is its role in social dynamics, which is a predominant concern in 
the youth. Users are associated with popularity and e-cigarettes facilitate social gains. 
Barrington-Trimis et al found that psychosocial factors, such as home use, friends’ use of 
and positive attitudes toward e-cigarette, were strongly associated adolescent use of e-
cigarettes [2]. For example, users able to cloud chase, which involves performing tricks 
from exhaled e-cigarette smoke, gain social standing and status from peers. And its sleek 
and modern design only contributes more to this image. Coupled with the flavored e-
juices and the directed marketing done by e-cigarette companies, there is no question as 
to why ENDS use has proliferated in the youth population.   
 
Flavored E-liquids  
 
A clear and leading factor in the rise in adolescent tobacco use in recent years is 
the flavors of e-liquids that directly facilitates the first use by adolescents. Of the 
adolescents who have vaped, most start with menthol or flavored products. Over 7700 
unique flavors are available to attract adolescents with their novelty [52] and a 
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palatability that masks the flavor and harshness of tobacco. Ambrose et al’s study in 2015 
of 13,651 youth supports this. They showed that the first ENDS product used by 81% of 
ever-user youth participants was flavored and 85.3% of product use in past 30-day e-
cigarette youth use was of flavored products [1]. Youth and young adults continue to use 
e-cigarettes because “they come in flavors I like,” as stated by 81.5% of youth, 12 to 17 
years old. Only 66.4% of adults 25 years and older in the study, in comparison, 
contributed the flavor of the e-liquid to their use of e-cigarettes. This discrepancy can 
possibly be explained through the dissonance between the sweet and fun flavors with the 
toxicity of nicotine. It can be hard to imagine that such flavors are bad for the body. 
37.5% of middle school and high school students believe that intermittent e-cigarette 
smoking causes little to no harm [47]. E-cigarette companies have been able to capitalize 
on these flavors while flavors other than menthol in combustible cigarettes have been 
banned to limit appeal to adolescents. The false security of flavors coupled with the lack 






Table 4: Leading reasons for non-cigarette tobacco product use among past 30-day 
tobacco users, by product—population assessment of tobacco and health study 
youth respondents aged 12-17 years, 2013-2014 [1] 
 
Marketing Towards Teens  
 
 Targeted marketing to teens is a serious issue that directly influences the 
prevalence of illicit teen e-cigarette use. Companies have invested the bulk of their 
resources in marketing in mainstream media and on the internet. Such channels include 
magazines, retailer point-of-sale ads, product placement, and television commercials, 
which is prohibited of cigarette manufacturers. Online direct-to-consumer marketing that 
allows brands to interact directly with targeted audiences and potential customers is 
mostly done through social media platforms such as Twitter, Facebook, Instagram, 
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Reddit, and YouTube, where adolescents frequent most regularly [34]. In 2016, 78.2% or 
20.5 million middle school and high school students were estimated to have been exposed 
to e-cigarette advertisements from any source, with 68.0% having seen an ad at a retail 
store, 40.6% on the internet, and 37.7% on television [31]. Through such marketing, e-
cigarettes in the adolescent population are socially accepted and are even admired. This is 




 A pioneer and leader of the e-cigarette market is the company JUUL Labs, which 
held 73.4% of the e-cigarette market share in July 2019 [21]. According to the CDC 2019 
National Youth Tobacco Survey, more than 59% of high school ENDS users reported 
that JUUL Labs was their brand of choice. JUUL Labs exemplifies the dangerous 
potential of e-cigarettes.  
JUUL Labs revolutionized the e-cigarette market through its innovative use of 
nicotine salts rather than free base nicotine that was the norm at the time. Nicotine salts, 
JUUL Labs reports, are less harsh upon inhalation because nicotine salts are closer to 
physiologic pH and do not activate alkaline sensitive protective mechanisms in the lungs. 
This allows for the 0.7 ml of nicotine per pod, which is equivalent to 20 combustible 
cigarettes, providing the same satisfaction as smoking a CC. JUUL pods are also 
absorbed with similar efficiency to nicotine in combustible cigarettes, adding to this 
satisfaction. Although this has been linked to greater adherence to cessation, it also 
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appeals to immature smokers who do not have a tolerance to inhaling anything other than 
air. They are able to vape JUUL e-cigarettes with less coughing and harshness but 
become dependent on the greater concentration of nicotine. This also perpetuates the 
pervasive misbelief that e-cigarettes are harmless because users do not respond to the 
JUUL as they do combustible cigarettes, thus dissociating e-cigarettes and traditional 
cigarettes and toxicity even more.   
The marketing tactics of JUUL Labs also demonstrates the harm potential of the 
current trajectory of e-cigarettes. JUUL Labs spent $2.1 million on marketing between 
2015 and 2017, more than $1 million of which was used to market its products online 
through campaigns on Twitter, Instagram, YouTube, and social media influencers [22]. 
Themes of its campaigns included pleasure/relaxation, socialization/romance, flavors, 
cost savings and discounts, holidays/seasons, style/identity, and satisfaction [23]. Rarely 
its purported function as a smoking cessation tool and harm-reduced nicotine product is 
at the forefront of its advertisements. Consequently, nearly two thirds of current JUUL 
users 15 to 21 years old are unaware that JUUL products always contain nicotine [49]. 
The intentions of JUUL Labs can be interpreted through its marketing campaigns; that 




CONSEQUENCES OF E-CIGARETTE USE 
 
 With the growing numbers of adolescent e-cigarette users worldwide, it is 
essential that the consequences, both short and long term, of vaping be understood in the 
context of the adolescent. Adolescence is a pivotal time for growth and development and 
the effects of e-cigarettes, its constituents, and its aerosolized nature on this development 
are damaging. The latent consequences of e-cigarettes are compounded in adolescents, 
who are in critical stages of brain development, habit formation, and social development. 
 
Effects of E-cigarette Aerosol and its Constituents  
 
 The research done on the effects of e-cigarettes have been conducted through 
mouse models, in vitro human samples, and in vivo and applied to the general population, 
including adolescents.  
 
Reported Symptoms of E-cigarette Use 
 A cross-sectional telephone survey was conducted of U.S. youth ages 13 to 17 to 
assess the symptoms experienced by ever-user adolescents: 42.3% reported cough, 31.5% 
had experienced dizziness or lightheadedness, 25.4% had headaches or migraines, 14.9% 
reported dry or irritated mouth and throat, 13.7% complained of shortness of breath, 3.5% 
experienced a change in or loss of taste, and 5.7% also experienced other symptoms 




 Significant research has been done to ascertain the physiologic effects that vaping 
has on the pulmonary system. Symptomatically, the risk of chronic bronchitis including 
chronic cough and phlegm, asthma, chronic obstructive pulmonary disease (COPD), and 
dyspnea increases with vaping [24]. These symptoms can be attributed to the altered 
physiological equilibrium of the pulmonary system. The e-cigarette aerosol causes 
erythematous and irritable airway mucosa due to an increase in pro-inflammatory 
cytokine secretions, induced alveolar macrophage apoptosis, and impairment of 
neutrophil and macrophage phagocytosis [24]. Impaired phagocytosis, coupled with 
decreased ciliary beating as a result of exposure to e-cigarette vapor, leaves the lungs 
susceptible to pathogens as the lung’s immune system is unable to clear them out [24]. 
There is also altered expression of genes involved in oxidative and xenobiotic stress 
pathways that can contribute to the inflammation of the airways [24].  
Vaping has also been found to inhibit the cystic fibrosis transmembrane 
conductance regulator (CFTR) channel and its mediated chloride secretion, inducing 
airway epithelial dehydration, in vitro [24]. Although its effects on the CFTR channel in 
vivo are not yet confirmed, the humectants, PG and VG, of the e-liquid do increase mucin 
expression and decreased membrane fluidity in the primary airway epithelia after vaping 
[24]. These observations are consistent with each other and the effects on endocytosis 
that have been observed, as decreased membrane fluidity may affect endocytosis. 
Increased mucin and dehydration only amplify the inhibition of the mucociliary clearance 




 Research on the effects of e-cigarette aerosol extract (eCAE) on the 
cardiovascular system are expansive, linking eCAE to angiogenesis, oxidative stress, 
endothelial dysfunction, sympathetic nerve system activation, platelet activation and 
anticoagulation inhibition, and cardiac remodeling. Kennedy et al conducted a systematic 
review of these experimental studies. They found that eCAE exposure in human subjects 
leads to increases in heart rate and blood pressure and abnormalities in heart rate 
variability, suggesting sympathetic nerve activation by eCAE [26]. E-cigarette exposure 
also increases atherosclerotic risk in users due to the increase in ROS production and 
reduction of antioxidants after exposure [26]. Endothelial dysfunction, which also adds to 
atherosclerotic risk, was observed through disordered endothelial cellular structure, 
function and interactions in in vitro studies, vascular inflammatory markers and 
angiogenesis in mouse models, and increased arterial stiffness in human subjects [26]. 
Platelet homeostasis was also disrupted by eCAE exposure in all studies, suggesting an 
increase in thrombotic risk for those who use ENDS. Increases in endothelial (c)1q 
deposition, reactive hyperemia and murine left ventricular mass were also observed as a 
consequence of vaping but have not been identified or linked to cigarette smoking [26]. A 




Table 5: Summary of findings: the proposed complex pathogenic mechanisms of e-




 The relative novelty of ENDS, which first gained widespread popularity in the 
mid-2000s, restricts the availability of studies assessing the long-term consequences of e-
cigarette use, especially in vivo. Still, some e-cigarette smoke (ECS) studies with mouse 
models are being done, like the Tang et al study, to determine the correlation, if any, 
between ECS and cancer.  
In the Tang et al study, mouse models were exposed four hours per day, 5 days a 
week, for 54 weeks to one of three conditions [43]:  
1. ECS generated from e-juice with isopolypropylene glycol (PG) and vegetable 
glycerin (VG) at a 1:1 ratio (Veh) as the solvent; particulate matter 
concentration was maintained at 130 mg/m3 and the aerosol nicotine 
concentration at 0.196 mg/m3 in the chamber 
2. Veh generated with a e-cigarette aerosol generator set at a constant power  
(1.9 A, 4.0 V) 
3. Ambient filtered air (FA).  
The lungs, heart, liver, kidneys, intestine, pancreas, brain, spleen, and bladder of 
all surviving mouse models were prepared and stained with hematoxylin and eosin 
(H&E) to be reviewed by three separate pathologists. Bladder tissue slides were also 
stained with antibodies for the proliferation markers MCM-2 and PCNA and the basal 
cell marker KRT5. Upon gross review and histologic examination, they found that 22.5% 
of ECS mice, no Veh mice, and 5.6% of FA-exposed mice developed lung 
adenocarcinomas [43]. The bladder urothelium of 57.5% of ECS-exposed mice and 6.3% 
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of Veh mice had hyperplastic lesions, characterized by a significant increase of urothelial 
layers, expansion of KRT5-positive basal urothelial cells, and a distinct elevation of the 
cell proliferation markers MCM-2 and PCNA, while no control mice displayed such 
pathology [43]. The statistically significant observations of this study support the role 
ECS on carcinogenesis in lung epithelium and possibly urothelium.  
Tang et al speculate that long-term exposure to ECS allows the accumulation of 
DNA damage and transformation of epithelium into cancerous cells. This conclusion 
builds on their previous findings that short-term exposure to ECS and nicotine and 
nicotine-derived nitrosamine ketone induces γ-OHPdG and O6-methyl-dG mutations, in 
lung and bladder epithelium, and inhibit DNA repair in lung tissues of mice.  
There is controversy regarding the carcinogenic properties of nicotine and ECS 
due to inconsistent results of the research currently available. The prevailing thought is 
that nicotine is non-carcinogenic. The researchers in this study acknowledge the 
conflicting studies and highlight that their experimental data in model systems simply 
warrants deeper study. Studies assessed nicotine’s carcinogenic potential through 
delivery via drinking water, subcutaneous injections, and air-vaporized, whereas Tang et 
al studied ECS. Possibly, the method of nicotine delivery afforded by the e-cigarette, 
which aerosolizes nicotine into smaller particles compared to tobacco smoke and allows 
nicotine to deposit deeper into the alveoli of the lungs, is responsible for the opposing 
results. Nicotine from tobacco smoke mainly settles in the upper aerodigestive tract 




Table 6: Lung adenocarcinoma incidence in ECS-, Veh-, and FA-exposed mice [43] 
 
Graduation from E-cigarettes: Catalyst Model 
 
 The catalyst model was proposed by Schneider and Diehl in 2016 as a model for 
the relationship and the influence of e-cigarette use on the initiation of cigarette smoking 
in adolescents. The model consists of two stages: the transition from ‘no use’ to ‘e-
cigarette use’ and the transition from ‘e-cigarette use’ to ‘tobacco use.’ Schneider and 
Diehl hypothesized that the first transition is facilitated through a variety of factors, 
including flavor, health, price, role models, concealment, and acceptance [39]. The 
subsequent transition can be attributed to the addiction hypothesis, accessibility 
hypothesis, and the experience hypothesis [39]. The addiction hypothesis attributes the 
transition to the addictive nature of nicotine in e-cigarettes and the natural progression to 
seek out greater concentrations of nicotine and a more satisfying “hit” that is available 
with combustible cigarettes. The accessibility hypothesis explains that e-cigarettes and 
traditional cigarettes are often available through the same commercial and social sources 
and access to e-cigarettes would mean access to cigarettes, encouraging the transition. 
The experience hypothesis highlights the similar habitual and ritual processes between 
ENDS and combustible cigarettes in facilitating the transition.  
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Every adolescent navigates through these stages influenced by different factors 
that determine their trajectory. But those adolescents who transition through the first 
stage are at greater risk for tobacco use because e-cigarette use acts as a catalyst that 
facilitates the transition from ‘no use’ to ‘tobacco use.’ Even an isolated incidence of e-
cigarette use can encourage smoking uptake in this model because the experience 
hypothesis attributes experience, even minimal, with the habitual and ritual procedures of 
smoking to ease the initial transition to combustible cigarettes. Thus, it is important to 
address and regulate the different potential initiation factors.   
 The catalyst model has been repeatedly supported through various longitudinal 
studies that assess the relationship between e-cigarette use and tobacco smoking. Bold et 
al conducted a survey in Connecticut high schools over a three-year period, with each 
year referred to as a wave, where students would anonymously report their use [5]. 
Students who used e-cigarettes in the past month at wave 1 had an odds ratio (OR) of 
7.08, which means that they are 7 times more likely to report combustible cigarette use at 
wave 2 than students who were not vaping. With an OR of 3.87, individuals who vaped 
e-cigarettes in the past month at wave 2 were almost 4 times more likely to have smoked 
cigarettes than those who did not use e-cigarettes. The study also revealed that e-cigarette 
use and cigarette smoking frequency increased over time, demonstrated by the 26% of 
cigarette users and 20.5% of e-cigarette users who reported using their respective nicotine 
products 21–30 days out of the past month in wave 3 compared to 15.3% and 10.3% in 
wave 1, respectively. This supports the growing dependency of adolescents on the 
nicotine products that they use.  
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 Another study by Berry et al conducted a similar survey study using data from the 
Population Assessment of Tobacco and Health Study (2013-2016) [3]. They found that 
prior e-cigarette use was associated with an OR of 4.09 or a more than 4 times the odds 
of ever cigarette use compared to no prior tobacco use. It also revealed an OR of 2.75 for 
current cigarette use. The study estimated that e-cigarettes were likely responsible for 
22% of new ever cigarette use and 15.3% of current cigarette use, which amounts to 
nearly 180,000 new cigarette users.  
 Whatever the influences that facilitate the progression from e-cigarette to 
combustible cigarette use and whatever model represents this transition, it is clear from 
the numerous studies conducted that e-cigarettes play a catalytic role in enabling it. This 
graduation from e-cigarettes to combustible cigarettes would only increase the toxicity to 
which they are exposed.  
 
Nicotine on the Developing Adolescent Brain 
 
 Nicotine and its effects have been studied at great depths due to the prevalence of 
combustible cigarettes. However, with the proliferation of e-cigarettes, especially within 
the adolescent population, nicotine’s toxicity has a greater reach. It is therefore important 
to highlight the effects that nicotine can have on the developing brain. 
 Adolescence is marked by the reorganization and maturation of regions of the 
brain necessary for mature cognitive and executive function, working memory, reward 
processing, emotional regulation, and motivated behavior through the regulation of 
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nicotinic acetylcholine receptors (nAChRs) [51]. Nicotine exposure, which alters the 
cholinergic system, during adolescence induces acute and long-term effects in these 
regions, such as the prefrontal cortex, nucleus accumbens (NAc), and amygdala [38]. 
These changes translate to impairments in working memory and verbal memory during 
periods of abstinence, changes in drug sensitivity and reward-related manifestations in 
adulthood, more severe dependence during adolescence, and deficits in attentional 
performance, impaired serial pattern learning, impaired context conditioning and 
increased anxiety and depressive-like behaviors in adults [38]. One study demonstrated 
the cognitive effects of nicotine on adolescence via mouse models. Adolescent mice were 
exposed to nicotine for 12 days, from post-natal day (PND) 38 to 50, and, after 30 days of 
abstinence, exhibited deficits in contextual but not cued fear conditioning. Contextual 
fear conditioning is hippocampus-dependent and such deficits highlights the learning 
deficits from nicotine administration. They also showed the learning deficits are isolated 
to adolescence because the same effects were not observed in adult mice when receiving 
the same treatment [38].  
 Other studies suggest nicotine induces brain plasticity. Plasticity, possibly 
dependent D1 dopamine receptors, has been observed in the NAc shell. There is also 
altered expression of genes involved in neuroplasticity, leading to structural changes such 
as decreases in apical dendrite length in the hippocampal CA1 region and increases in 
dendritic length in medium spiny neurons from the NAc shell [38]. Long-term nicotine 
use also leads to the suppression of nicotine-induced elevation of striatal dopamine and 
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norepinephrine levels, which initially affects the brain’s control of motivation, reward, 
and pleasure [38]. 
 
Gateway hypothesis   
 
 Not only would e-cigarettes drive adolescents to smoke combustible cigarettes, 
nicotine can serve as a gateway drug that lowers the youths’ threshold for addiction to 
opioids, alcohol, and other agents. This is the Gateway Hypothesis. Epidemiological data 
supports this as smokers above the age of 12 are 5 times more likely to use illicit drugs 
and marijuana use in adulthood is over 3 times more likely in smokers who began 
smoking before the age of 13 compared to non-smokers [38].  
 Mojica et al demonstrated that brief nicotine exposure during early adolescence 
enhances drug-related learning [33]. In the study, rats were administered nicotine, two 
intravenous injections of 0.03 mg/kg/0.1 ml, or saline for four days during early 
adolescence or adulthood, PND 28-31 and PND 86-89 respectively. The rats were then 
placed in operant self-administration conditioning chambers with nose pokes reinforced 
by cocaine daily for 2-hour cocaine self-administration sessions for at least 12 days or 
until acquisition requirements were met. All adolescent rats pretreated with nicotine met 
the acquisition requirements while 13 of 18 adult rats met the requirements, supporting 
that nicotine pretreatment significantly enhanced drug-related learning in adolescents but 




Figure 4: Age differences in the effect of nicotine pretreatment on the acquisition of 
cocaine self-administration [33] 
 Larraga et al demonstrated that nicotine administration in adolescence increased 
alcohol intake, suggesting that adolescent nicotine exposure increased sensitivity to 
alcohol reward in adulthood, which supports the gateway hypothesis [29]. In the study, 
adolescent and adult mice self-administered alcohol, nicotine, or a combination of both in 
an intravenous self-administration paradigm. Then, the same mice, after maturing to 
adulthood, were evaluated for alcohol drinking via an in-the-dark (DID), 2-bottle choice 
test, with water and alcohol. The male rats that self-administered nicotine, with or in 
combination with alcohol, as adolescents drank more alcohol in adulthood than rats in the 
saline control group in all three test doses. Adult rats that self-administered alcohol and 
alcohol did not demonstrate increased alcohol intake in the 2-bottle choice test. Notably, 
subsequent alcohol intake by female rats were unaffected by self-administration of 




Figure 5: Nicotine self-administration during adolescence increases subsequent 





 EVALI, or e-cigarette or vaping associated lung injury, is a diagnosis of exclusion 
where diagnosis is contingent on other potential etiologies being ruled out, absence of 
pulmonary infection, a recent history of vaping within 90 days, and abnormal chest 
imaging findings of pulmonary infiltrates [7]. Symptoms usually present gradually, first 
with mild shortness of breath and/or chest pain that progresses to severe difficulty 
breathing. It presents with a wide range of respiratory, gastrointestinal, and constitutional 
symptoms, including cough, dyspnea, chest pain, nausea, vomiting and diarrhea, fatigue, 




Potential Cellular and Molecular Mechanisms 
 This acute lung injury is characterized as a sterile exogenous pneumonitis-like 
reaction with variable degrees of diffuse alveolar damage, indicated by increased levels 
of club cell protein 16 (CC16), and substantial involvement of innate immune 
mechanisms [7]. In a healthy lung, the innate immune system functions in maintaining 
airway homeostasis, through lung surfactants, mucociliary clearance, and phagocytosis of 
inhaled particles. The immune cells that drive these physiological functions, and thus are 
the first responders following ENDS aerosol exposure, include airway epithelial cells 
(AECs), alveolar macrophages, and polymorphonuclear cells (PMNs) [7].  
 E-cigarette aerosol exposure, as previously discussed, increases the user’s 
susceptibility to infection due to dysfunction of the innate immune system. Users were 
found to have reduced levels of proteins CSF-1, CCL26, and eotaxin-3 that are essential 
for mucosal host defense [7]. PMN function and its neutrophil-derived extracellular traps 
(NETosis) are also disrupted as a result of e-cigarette aerosols and inhibit the appropriate 
immune response from the lungs. The compromised immune system results in more 
inflammation from increased rates of infection. The chemical assault from e-cigarette 
aerosols also contribute to pneumonitis. Higher concentrations of C-reactive protein and 
inflammasome complex proteins which promote cellular pyroptosis have been observed 
[7]. However, this increased inflammation is not resolved, also as a consequence of 
ENDS use. Exposure to ENDS changes the phenotype and function of alveolar 
macrophages, suppressing their phagocytic activity that helps clear the insult, both 
apoptotic cells and harmful irritants, and thus resolve inflammation. The chronic 
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inflammation can lead to alveolar damage and potentially EVALI. However, the exact 
mechanism and the culprit is unknown at this time.  
 
Role of Vitamin E Acetate 
There is currently no single substance that is conclusively implicated to cause 
EVALI. Recent histopathological reports showed the presence of blackened lungs, which 
can suggest the involvement of PAHs in EVALI [7]. However, prevailing thought 
supports that vitamin E acetate, an additive most notably in THC-containing vaping 
products, is strongly linked to the EVALI outbreak [37, 45], particularly in products that 
are distributed through illicit channels. Vitamin E acetate, available as a vitamin 
supplement and in many cosmetic products, does not cause harm when ingested or 
applied to the skin. When inhaled, however, vitamin E acetate has been suggested to 
interfere with normal lung function.  
Blount et al performed isotope dilution mass spectrometry using bronchoalveolar 
lavage (BAL) fluid samples collected from 51 EVALI patients, of which 25 patients were 
confirmed and 26 were suspected, and 99 healthy participants to measure levels of 
several priority toxicants, such as vitamin E acetate, diluent terpenes, and medium-chain 
triglyceride oils [4]. They found vitamin E acetate in 48 of the 51 (94%) EVALI patients’ 
BAL fluid samples and no other toxicants from either group, except coconut oil and 
limonene in 1 EVALI patient each. 47 of the 50 (94%) EVALI patients for whom 
laboratory or epidemiologic data was available either had THC or its metabolites detected 
in their BAL fluid or reported using THC vaping products in the 90 days prior to 
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symptom onset. 30 of 47 (64%) case patients had detectable nicotine or its metabolites in 
their BAL fluid [4].  
 The presence of vitamin E acetate in the vast majority of BAL fluid samples in 
EVALI cases highlights the strong link between vitamin E acetate and EVALI, though no 
causal claims can be made at this point. Also, the prevalence of THC-product vaping in 
affected EVALI patients supports its role in EVALI onset.  
 
Incidence  
There was a sharp rise of EVALI cases in August 2019, which peaked in 
September 2019. Since then, there has been a gradual but consistent decline in cases 
possibly due to increased awareness, removal of vitamin E acetate in some products, and 
law enforcement actions related to some illicit products [37]. 
As of January 14, 2020, there has been a total of 2,688 hospitalized EVALI cases 
and 60 confirmed deaths in the US reported to the CDC [37]. The median age of the 
deceased patient was 51 years, with patients ranging from 15 to 75 years old. Among the 
hospitalized cases reported as of January 14, 2020, 66% of patients were male and the 
median age was 24 years and ranged from 13 to 85 years old. 15% of those patients were 
under 18 years old, 37% of patients were 18 to 24 years old, 24% were 25 to 34 years old, 
and 24% of patients were older than 35 years old [37]. 2,022 of the 2,688 patients 
provided data on substance use, with 82% reporting using THC-containing products, 33% 
using THC-containing products exclusively, 57% vaping nicotine-containing products, 
and 14% reporting exclusive use of nicotine-containing products [37]. Of the hospitalized 
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EVALI patients, younger patients, aged 13 to 17 years old, were significantly more likely 
to obtain ENDS from informal sources. 94% of patients in this age range had acquired 
their THC-containing products only from informal sources compared to 62% of those 
aged 45 years or older. 42% of EVALI patients aged 13 to 17 years acquired nicotine-
containing ENDS from only informal sources versus 12% of the patients 45 years or 
older. 
Figure 6: Number of Hospitalized EVALI Cases or Deaths Reported to CDC as of 
January 21, 2020 [37] 
 
Implications  
The severity of EVALI and its prevalence in adolescent populations demonstrates 
the potential harm that e-cigarettes pose to adolescents, who are more likely to use e-
cigarettes than their adult counterparts. EVALI cases are also more strongly linked to 
products obtained through illicit channels, which was the most common method of 
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acquisition in the patients aged 13 to 17 years. This can be attributed to the age 
restrictions, rightly so, of ENDS sales that force youth to obtain e-cigarettes from illegal 
sources. These correlations highlight the targeted susceptibility of adolescents to EVALI, 








ENDS have pervaded the adolescent demographic, integrating itself as a staple in 
youth culture through its accessibility, concealability, status, and flavors. The intentional 
marketing of e-cigarettes, that targets teens, only tightens its grip on youth, as 
exemplified by JUUL Labs. And as ENDS use has increased amongst adolescents, so 
have its consequences. Particularly of concern in the youth population is the graduation to 
combustible cigarettes that compounds the effects of nicotine on the developing brain in 
this critical stage and deepens the Gateway hypothesis. ENDS do have the potential for 
smoking cessation or as an alternative smoking product for already combustible cigarette 
smokers able to make a complete switch to e-cigarettes. But in the end, however, the 
long-term health consequences of ENDS are still unknown and so e-cigarettes should be 
used with caution and definitely not by minors. Its pervasiveness in youth culture 
emphasizes the necessity of regulation to control adolescent exposure. A coordinated 
effort from policy makers, public health agencies, healthcare providers, researchers, and 










With policy changes, the issue presents itself to make potentially lower risk 
nicotine products intended for smokers accessible, while simultaneously discouraging use 
by non-smokers, especially youth. 
 
Current Policies 
FDA regulation of the tobacco industry first began with the Family Smoking 
Prevention and Tobacco Control gave, which allowed the FDA to regulate the 
manufacture, import, packaging, labeling, advertising, promotion, sale, and distribution 
of ENDS, including components and parts of ENDS but excluding accessories [46]. In 
2016, the Child Nicotine Poisoning Prevention Act of 2016 was passed in response to the 
more than 8,000 accidental e-liquid exposures in children younger than 6 years old 
reported by U.S. poison control centers between 2012 to 2017 [15] and requires child-
resistant packaging of E-juices. By August 2018, all covered tobacco products were 
required to bear tobacco labeling and warning statements on packaging and 
advertisements [9, 46]. And finally in January 2020, the FDA announced that it will ban 
all flavored e-cigarette pods except tobacco and menthol. This announcement was much 
less stringent than their previous announcement in September 2019 to “clear the market” 
of flavored e-cigarette and vape products. Nearly 50% of study participants in Du et al’s 
study reported that they would find a method to buy their preferred E-liquid flavor or add 
flavoring agents themselves if flavors were banned [14].  
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In response to this new regulation and JUUL Labs halting sales of some flavors 
after scrutiny for its leading role in the youth e-cigarette epidemic, Puff Bars have grown 
in popularity. Puff Bar is a relatively new e-cigarette product that is similar in design and 
functionality to the popular JUUL but is disposable. They are able to sell flavors like 
O.M.G (orange, mango, guava) because its design for one-time-use allows it to bypass 
federal policy that regulates flavored e-cigarettes [48]. Currently, such regulation only 
applies to closed system e-liquid cartridges and not to refillable cartridges or disposable 
products. Puff Bar is only one brand of tens that has taken advantage of this loophole. 
Recently the U.S. House of Representatives passed the Protecting American 
Lungs and reversing the Youth Tobacco Epidemic Act of 2020 (H.R. 2339) that would 
ban the use of characterizing flavors in all tobacco products, include vape and e-cigarette 
products, but has not been brought to a vote in the Senate.  
 
Standardization  
Much of the regulation bypassing is possible because ENDS are currently 
heterogeneous, coming in many styles, constituents and their concentrations, mechanical 
features, and more. On top of that, the e-cigarette industry is evolving quickly. By 
standardizing ENDS and the E-liquids, there can be more efficient and consistent 
regulation of ENDS. Standardization can include battery power, constituents, nicotine 
concentrations, marketing, and safety requirements. In England, for example, where the 
quality, safety, and marketing of ENDS are regulated and nicotine concentrations are 
capped at less than half of that permitted in the U.S., fewer 11-18 year olds have tried e-
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cigarettes (15.4%) and adults most commonly use ENDS products to stop smoking [11, 
32, 45]. Regulating and standardizing ENDS will also benefit research, providing internal 
and external validity of the studies that can then be a source of reliable and applicable 
information for health workers, teachers, parents, and adolescents. Routine screening 
procedures can be developed and appropriate care given with such information.  
 
Age Regulation 
Age regulation is also an important step that is necessary to mitigate the harms of 
e-cigarettes. The new federal law to ban the sale of all tobacco products, including e-
cigarettes,  to persons under 21 years of age will not only legally inhibit a larger 
population of youth from obtaining tobacco products, but it will also deter the 
accessibility of illicit ENDS for adolescents. This increase in age gap between the 
susceptible adolescent and the adult who has access to e-cigarettes distances the 
connection a teen has to a peer who can buy it for them, making it much harder and less 
likely for adolescents to vape.   
 
Call to Action 
 
 The unknown consequences, especially long-term, and harm potential of ENDS 
highlights the unchartered territory that we still have to uncover through research. The 
current knowledge, that demonstrates the pulmonary, cardiac, neurologic, and addictive 
effects of e-cigarettes, emphasizes the urgency of this research, especially due to the 
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projected growth of the industry. Future studies should not only examine the 
physiological consequences of vaping itself but also its epidemiologic effects and the 
efficacy of current regulation, in order to guide the adoption of future policies. With new 
research much also come equal efforts in teaching and communicating actionable 
recommendations to health professionals, public health officials, and the general public 
about safe ENDS use and the potential harms. We must dispel the widespread 
misconception that e-cigarettes are without harm. 
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